Steven Sell - 14 Apr 2024 Form 4 Insider Report for agilon health, inc. (AGL)

Role
CEO & President, Director
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Apr 2024
Transactions value $
-$38,981
Form type
4
Filing time
17 Apr 2024, 21:38:05 UTC
Previous filing
21 Nov 2023
Next filing
16 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +252,243 +3% $0 336,322 15 Apr 2024 Direct F1, F2
transaction AGL Common Stock Tax liability -$38,981 -7,875 -2.34% $4.95 328,447 14 Apr 2024 Direct F2, F3
holding AGL Common Stock 47,590 14 Apr 2024 By trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Award $0 +415,130 $0 415,130 15 Apr 2024 Common Stock 415,130 $4.46 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in four equal installments on each anniversary of April 15, 2024, subject to continued employment.
F2 Includes restricted stock units.
F3 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F4 These shares of common stock are held in the Steven J. Sell and Margaret D. Williams Revocable Inter Vivos Trust Agreement.
F5 Options that vest in four equal installments on each anniversary of April 15, 2024, subject to continued employment.